Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer 1.1 Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
From the U.S. FDA-approved label for Letrozole. Full label: DailyMed.
Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer 1.1 Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. 1.2 Extended Adjuvant Treatment of Early Breast Cancer Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.
From the U.S. FDA-approved label for Letrozole. Full label: DailyMed.
Letrozole tablets are taken orally without regard to meals: Recommended dose: 2.5.mg once daily Patients with cirrhosis or severe hepatic impairment: 2.5 mg every other day 2.1 Recommended Dose The recommended dose of letrozole tablet is one 2.5 mg tablet administered once a day, without regard to meals. 2.2 Use in Adjuvant Treatment of Early Breast Cancer In the adjuvant setting, the optimal duration of treatment with letrozole is unknown. In both the adjuvant study and the post approval adjuvant study, median treatment duration was 5 years.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Pregnancy: Letrozole can cause fetal harm. Pregnancy: Letrozole can cause fetal harm. Known hypersensitivity to the active substance, or to any of the excipients. Known hypersensitivity to the active substance, or to any of the excipients. Pregnancy Known hypersensitivity to the active substance, or to any of the excipients
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Decreases in bone mineral density may occur. Consider bone mineral density monitoring Increases in total cholesterol may occur. Consider cholesterol monitoring. Fatigue, dizziness and somnolence may occur. Exercise caution when operating machinery Embryo-Fetal Toxicity: Can cause fetal harm when administered to pregnant women. Obtain a pregnancy test in females of reproductive potential. Advise females of reproductive potential to use effective contraception 5.1 Bone Effects Use of letrozole may cause decreases in bone mineral density (BMD). Consideration should be given to monitoring BMD.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in greater detail in other sections of the labeling. Bone effects Increases in cholesterol Fatigue and Dizziness The most common adverse reactions (greater than 20%) were hot flashes, arthralgia; flushing, asthenia, edema, arthralgia, headache, dizziness, hypercholesterolemia, sweating increased, bone pain and musculoskeletal.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
169 products from 141 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Fempro 2.5mg Tablet | Letrozole (2.5mg) | Cipla Ltd. | |
| Lerozol 2.5 mg Tablet | Letrozole (2.5 mg) | Square Pharmaceuticals Ltd. | |
| Letoripe 2.5mg Tablet | Letrozole (2.5mg) | RENATA LIMITED | |
| Mamazol 2.5mg Tablet | Letrozole (2.5mg) | Khandelwal Laboratories Pvt Ltd | |
| Trozet 2.5mg Tablet | Letrozole (2.5mg) | Fresenius Kabi pharmaceuticals | |
| Anzen 2.5mg Tablet | Letrozole (2.5mg) | Sanzyme Ltd | strip of 10 tablets |
| Apletro 5mg Tablet | Letrozole (5mg) | Apkavit Lifesciences | strip of 5 tablets |
| Arobit 2.5mg Tablet | Letrozole (2.5mg) | Eskag Pharma Pvt Ltd | strip of 10 tablets |
| Arolet Tablet | Letrozole (NA) | Estragen Pharma | strip of 10 tablets |
| Arvilet 2.5mg Tablet | Letrozole (2.5mg) | Arvincare Pharma | strip of 10 tablets |
| Bd Letro 2.5mg Tablet | Letrozole (2.5mg) | BDR Pharmaceuticals Internationals Pvt | strip of 10 tablets |
| Beelet 2.5mg Tablet | Letrozole (2.5mg) | Biocin Genetics & Pharma | strip of 5 tablets |
| Bestova L 2.5mg Tablet | Letrozole (2.5mg) | Akumentis Healthcare Ltd | strip of 10 tablets |
| Brelet 2.5mg Tablet | Letrozole (2.5mg) | East West Pharma | strip of 5 tablets |
| Briteova 2.5 Tablet | Letrozole (2.5mg) | Medgrow Health Care | strip of 5 tablets |
| Briteova 5 Tablet | Letrozole (5mg) | Medgrow Health Care | strip of 5 tablets |
| Brylet Tablet | Letrozole (2.5mg) | Bryson Pharmaceutical Llp | strip of 10 tablets |
| Caditraz 2.5mg Tablet | Letrozole (2.5mg) | Cadila Pharmaceuticals Ltd | strip of 10 tablets |
| Canctroz 2.5mg Tablet | Letrozole (2.5mg) | Lamiaceae Healthcare | strip of 10 tablets |
| CCQ-L Tablet | Letrozole (2.5mg) | TTK Healthcare Ltd | strip of 5 tablets |
| Celofem 2.5mg Tablet | Letrozole (2.5mg) | Celon Laboratories Ltd | strip of 10 tablets |
| Ceolet 2.5mg Tablet | Letrozole (2.5mg) | Cieo Remedie | strip of 5 tablets |
| Chemlet 2.5mg Tablet | Letrozole (2.5mg) | Neon Laboratories Ltd | strip of 10 tablets |
| Clomipure-L Tablet | Letrozole (2.5mg) | Akumentis Healthcare Ltd | strip of 5 tablets |
| Clomset L Tablet | Letrozole (NA) | Dahlia Pharmaceutical Pvt Ltd | strip of 5 tablets |
| Concilet Tablet | Letrozole (2.5mg) | Floracia Healthcare Pvt Ltd | strip of 5 tablets |
| Conizet 2.5mg Tablet | Letrozole (2.5mg) | Novalab Healthcare Pvt Ltd | strip of 5 tablets |
| Culet 2.5mg Tablet | Letrozole (2.5mg) | Cureill Pharma Pvt. Ltd. | strip of 5 tablets |
| DavaIndia Letrozole 2.5mg Tablet | Letrozole (2.5mg) | Davaindia Generic Pharmacy | strip of 5 tablets |
| E-Ova L 2.5 Tablet | Letrozole (2.5mg) | Koye Pharmaceuticals Pvt ltd | strip of 5 tablets |
Showing 30 of 169 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Letrozole is recorded in the NepalDoc medicine catalog for: Breast cancer.
For Breast cancer: Capecitabine, Epirubicin, Melphalan, Norethisterone, Paclitaxel, Tamoxifen.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.